In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against clinical isolates of meropenem-non-susceptible Pseudomonas aeruginosa: A two-centre study. [electronic resource]
Producer: 20210209Description: 334-338 p. digitalISSN:- 2213-7173
- Azabicyclo Compounds -- pharmacology
- Blood -- microbiology
- Bronchoalveolar Lavage Fluid -- microbiology
- Ceftazidime -- pharmacology
- Cephalosporins -- pharmacology
- Drug Combinations
- Drug Resistance, Bacterial -- drug effects
- Humans
- Meropenem -- pharmacology
- Microbial Sensitivity Tests
- Pseudomonas Infections -- microbiology
- Pseudomonas aeruginosa -- drug effects
- Sputum -- microbiology
- Tazobactam -- pharmacology
- Trachea -- microbiology
- Turkey
- Urine -- microbiology
- beta-Lactams -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.